SEC Filing Update: #AVTX Avalo Therapeutics, Inc. : $7.44

Sector: Healthcare | YTD: 🔽 -56.18% The SEC disclosed Today (29-OCT-2026) that Trails Edge Capital Partners, LP has INCREASED #AVTX Shares by 214.36% 🟢 * Previous Holdings: 891.88K Shares * Current Holdings: 2.80M Shares * Increase+1.91M * Increased(%)+214.36% * Ownership: 5.2% * Estimated Investment Value: $17.19M https://www.thinksabio.com/reports/isr/AVTX Institutional ownership in #AVTX has been steadily rising over the past 5 quarters in Shares: Q2 2025: 7.84M Q3 2025: 15.32M Q4 2025: 19.89M Q1 2026: 31.10M Q2 2026: 65.75M 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2115903000442962258